about
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptomsPercutaneous Tibial Nerve Stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic reviewTransurethral needle ablation of the prostateMetabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective studySystematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial CarPhotoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms.Predictive value of digital rectal examination for prostate cancer detection is modified by obesityWide-neck renal artery aneurysm: parenchymal sparing endovascular treatment with a new device.The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.Superficial bladder tumors in patients under 40 years of age: clinical, prognostic and cytogenetic aspects.Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.Scrotal extratesticular schwannoma: a case report and review of the literature.Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resectionPure intracorporeal laparoscopic radical cystectomy with orthotopic "U" shaped ileal neobladder.Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study.Transrectal-ultrasound prostatic biopsy preparation: rectal enema vs. mechanical bowel preparationA novel stepwise micro-TESE approach in non obstructive azoospermiaNew medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectivesToll-like receptors in prostate infection and cancer between bench and bedsideBladder weight and detrusor thickness as parameters of progression of benign prostatic hyperplasia.Quality of Life and Sexual Health in the Aging of PCa Survivors.Ultrasound imaging of the pelvic floor: where are we going?The correlation between metabolic syndrome and prostatic diseases.What determines whether a patient with LUTS seeks treatment? ICI-RS 2011.The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms.Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.Words of wisdom. Re: Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison.Measurement of post-void residual urine.Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin?Tolterodine in the Treatment of Male LUTS.Editorial Comment from Dr Presicce et al. to Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review.Smoking and Prostate Cancer: A Systematic Review.The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery.Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
P50
Q21256691-23E6BCBE-9679-495A-AD14-FC6F2BD63D81Q21256694-5CE5D7DB-CF5E-4EBA-BD7E-A9D895F99EBFQ28276946-08937A28-E6F0-4A98-BB99-95A1A13DC169Q28596648-B05ABB39-6CD5-4256-9B7C-A267F44817C7Q30975386-2E18E87C-A634-41FC-AF5F-5F4976B64B49Q33525737-F843F5E4-68AC-4719-BFC0-2C6764215CB1Q33778985-26983909-1727-463E-B3C5-5E3666E4B1D3Q33805561-A70A2728-C8E6-4D42-B368-B6267F5559CEQ33874785-CD5C7C9C-4C26-4F76-B2D0-C55BFFBD9843Q34399899-DAA42739-251D-465D-9F93-0ADB830E6042Q34408679-B8D60180-5359-49E6-B15A-4B051927A339Q34502903-5F7FE0CF-BDF0-4810-9C67-59FB6D2F77CDQ34761119-0A96FD22-E7E3-4E4C-A5D8-011CE407E997Q35158844-ADE28C58-72A3-4BDB-B5DC-07D534CE4466Q35204387-EA9E12E3-7059-4A5F-BA78-A7DBF1991EA8Q35430308-F0B79659-9FD1-4634-A340-DD105EA3D1B8Q35537838-623D4DA7-0180-4C28-B46E-B133397ECAB8Q35782419-140B67D3-261A-4312-8965-D41397BC8230Q35914795-1CA0B8EC-19B2-4C75-A283-1B7D0394B356Q35921548-1BFD90BC-B4F2-48E0-B725-3D6F5C60E9D6Q36016873-F676BDBB-E723-4F75-AD9C-633E5663E97BQ36133212-C9A22976-9D96-4C08-9E83-61F436D960C4Q37295411-22E7E190-FE91-459C-8365-EA4E8BDABBE3Q37630318-8B6F1237-5167-41FD-B12A-418DAE983709Q37686901-E9134DA3-EEB8-4568-9C92-F4107DAA0C0AQ37887656-FC3769F7-4928-41EA-8486-4A719F827C77Q37961334-54FA8EC5-A574-4D91-B852-D679E5F8A155Q37993486-2B8F4D42-C333-4A7A-AD4B-47340B52B5C4Q38034119-F5FCF58F-92B2-4D5F-B19A-1CAB389CB9C0Q38078597-85DB0603-56D2-41F3-A8F3-C4967855999AQ38118809-E5E9B6D3-E358-4783-8D3B-3C22BADE80B8Q38207768-C45471A5-1300-44D9-9929-F571FF1BA4C2Q38253841-16C478A6-030A-4EA5-B499-B6E477371A53Q38262803-59C7818E-3447-4654-8BAB-9B837F4C0AACQ38518351-29D04EF1-6CEA-4D1F-88FE-802A14E26BE0Q38543432-CC4CA147-EAE9-4C1B-B3DA-5CFD2BC53088Q38560036-C45F6BE0-1DF1-4A6D-BD60-4EB767164DC6Q38672191-65B7C222-C0C1-432F-A592-CBB259C41D21Q38901781-0852C8B5-D15B-4DAA-9EEA-176AFC30F249Q38905219-7B4F0561-9393-4A38-A421-3E19A8A210AA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cosimo De Nunzio
@ast
Cosimo De Nunzio
@en
Cosimo De Nunzio
@es
Cosimo De Nunzio
@fr
Cosimo De Nunzio
@nl
Cosimo De Nunzio
@sl
type
label
Cosimo De Nunzio
@ast
Cosimo De Nunzio
@en
Cosimo De Nunzio
@es
Cosimo De Nunzio
@fr
Cosimo De Nunzio
@nl
Cosimo De Nunzio
@sl
prefLabel
Cosimo De Nunzio
@ast
Cosimo De Nunzio
@en
Cosimo De Nunzio
@es
Cosimo De Nunzio
@fr
Cosimo De Nunzio
@nl
Cosimo De Nunzio
@sl
P106
P1153
6602296464
P21
P31
P496
0000-0002-2190-512X